VOYA INVESTMENT MANAGEMENT LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$95,000
-7.8%
20,9750.0%0.00%
Q4 2020$103,000
+15.7%
20,975
+40.0%
0.00%
Q3 2020$89,000
+154.3%
14,979
+13.5%
0.00%
Q2 2020$35,000
+34.6%
13,203
-1.4%
0.00%
Q1 2020$26,000
-72.3%
13,3960.0%0.00%
Q4 2019$94,000
-4.1%
13,396
+33.8%
0.00%
Q3 2019$98,000
-14.8%
10,0140.0%0.00%
Q2 2019$115,00010,0140.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders